Cellectis’.HEAL-101 cuts triglycerides 75% in preclinical mouse study
Cellectis says.HEAL-101 reduced triglycerides by 75% in mice in a preclinical study.
Related stories
Southside Bancshares Reports Third-Quarter 2026 Financial Results
Southside Bancshares reported results for the quarter ended September 30, 2026, including earnings per diluted common share of $0.93.
M impact | EQUITY | Oct 29, 2026, 09:46 AM UTC
Sheng Siong Q3 revenue rises 6.2% on store expansion
Singapore supermarket operator Sheng Siong reported a 6.2% rise in Q3 revenue, citing store expansion.
M impact | EQUITY | Oct 29, 2026, 09:45 AM UTC
Southside Bancshares Reports Q3 Pretax Profit of $34.26 Million
M impact | EQUITY | Oct 29, 2026, 09:45 AM UTC
Volkswagen CFO Expects China Auto Market at 19–21 Million Vehicles in 2030
Volkswagen's CFO expects the Chinese auto market to reach 19–21 million vehicles in 2030.
L impact | EQUITY | Oct 29, 2026, 09:44 AM UTC
Heimar to Report Third-Quarter Results
Heimar says it will publish third-quarter results.
M impact | EQUITY | Oct 29, 2026, 09:44 AM UTC
Volkswagen shares reverse course, rise 2%
M impact | EQUITY | Oct 29, 2026, 09:44 AM UTC